Miniaturized High-Throughput Amorphous Solid Dispersion Screening via Picoliter Volume 2D-Inkjet Printing of

Georgios Papakostas1, Philip A Corner1, Andrew L Hook2

  • 1Early Product Development & Manufacturing, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Charter Way, Macclesfield SK10 2NA, United Kingdom.

PubMed
Summary

Inkjet printing enables rapid screening of drug formulations using microgram quantities of material. This innovative approach accelerates the development of amorphous solid dispersions (ASDs) by efficiently evaluating drug-polymer interactions.

Related Concept Videos